{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T05:20:15Z","timestamp":1738300815798,"version":"3.35.0"},"reference-count":34,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2008,7,11]],"date-time":"2008-07-11T00:00:00Z","timestamp":1215734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J of Andrology"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>7\u2010alpha\u2010Methyl\u201019\u2010Nortestosterone (MENT) is a synthetic androgen more potent than testosterone (T) and cannot be reduced at 5\u2010alpha position. No important effects of MENT on prostate growth have been reported. However, little is known about the effect of MENT on benign prostatic hyperplasia (BPH) or prostate carcinoma (CaP). We evaluate the effect of MENT, T and dihydrotestosterone (DHT) on secretion, proliferation and gene expression of primary cell cultures from human BPH and CaP. Moreover, the effect of these androgens was examined in the presence of finasteride to determine the influence of the 5\u2010alpha reductase (5\u2010AR) activity on the androgenic potency. BPH and CaP primary cultures were treated with 0, 1, 10 and 100\u2003n<jats:sc>m<\/jats:sc>of T, MENT or DHT during 24 and 48\u2003h. Prostate\u2010specific antigen (PSA) was measured by micro particles immunoassay and proliferation rate by spectrophotometric assay (MTT) and by the immunochemical detection of the proliferation marker Ki\u201067. Gene expression of FGF8b (androgen sensitive gene) was evaluated by semi\u2010quantitative RT\u2010PCR. Results showed that MENT treatments increased PSA secretion and proliferation rate with a potency ranged between T and DHT. Similar effects of MENT were observed in both BPH and CaP cultures. The studies with finasteride showed that in BPH and CaP cells, the conversion of T into DHT significantly contributes to its effect on the proliferation and PSA secretion, and corroborated the resistance of MENT to the 5\u2010AR. The effect of MENT on the gene expression of FGF8b in CaP cells was similar to T and lower than DHT. It is concluded that MENT increases proliferative and secretory activities and gene expression on pathological prostate cells although in less extent than the active metabolite DHT. Furthermore, the fall of endogenous concentration of T during MENT treatment anticipates that this androgen will be of low impact for the prostate.<\/jats:p>","DOI":"10.1111\/j.1365-2605.2008.00906.x","type":"journal-article","created":{"date-parts":[[2008,7,11]],"date-time":"2008-07-11T10:20:42Z","timestamp":1215771642000},"page":"607-615","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma"],"prefix":"10.1111","volume":"32","author":[{"given":"Patricia","family":"Mendoza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor R.","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian","family":"Acevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Cabezas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Huidobro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"No\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique A.","family":"Castell\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,11,4]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-123-5-2187"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.10.3556"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021960"},{"key":"e_1_2_6_5_1","first-page":"943","article-title":"Evaluation of a tetrazolium\u2010based semiautomated colorimetric assay: assessment of radiosensitivity","volume":"47","author":"Carmichael J.","year":"1987","journal-title":"Cancer Research"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.2004.00509.x"},{"key":"e_1_2_6_7_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0031-6997(24)01480-7","article-title":"The control of prostate\u2010specific antigen expression and gene regulation by pharmacological agents","volume":"53","author":"Dixon S. C.","year":"2001","journal-title":"Pharmacological Review"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202624"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-022043"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)59889-4"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-128X(02)00184-8"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(03)00144-5"},{"key":"e_1_2_6_13_1","first-page":"227","article-title":"Molecular cloning of a complementary DNA encoding a prostate\u2010specific membrane antigen","volume":"53","author":"Israeli R. S.","year":"1993","journal-title":"Cancer Research"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.130.6.3677"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1939-4640.1997.tb01938.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(99)00143-0"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(94)90160-0"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.136.2.796"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1939-4640.1994.tb01682.x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0021-9258(19)45700-1","article-title":"Localization of the reduced nicotinamide adenine dinucleotide phosphate: \u03944\u20103\u2010ketosteroid 5\u2010alpha\u2010oxireductase in the nuclear membrane of the rat ventral prostate","volume":"247","author":"Moore R.","year":"1972","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_6_21_1","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1210\/jcem.84.10.6122","article-title":"Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium","volume":"84","author":"Negro\u2010Vilar A.","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/14.9.2200"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1939-4640.1997.tb02434.x"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-200405000-00009"},{"key":"e_1_2_6_25_1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/milmed\/160.8.416","article-title":"Microparticle immunoenzymatic assay for detection of prostate specific antigen: characterization of the technique and comparative analysis with a monoclonal immunoradiometric assay","volume":"160","author":"Sanchez de la Muela P.","year":"1995","journal-title":"Military Medicine"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.20354"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.14.7252"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.3109\/07853899309164168"},{"key":"e_1_2_6_29_1","first-page":"373","article-title":"7\u2010alpha\u2010methyl\u201019\u2010nortestosterone: an ideal androgen for replacement therapy","volume":"49","author":"Sundaram K.","year":"1994","journal-title":"Recent Progress in Hormone Research"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(99)00095-5"},{"key":"e_1_2_6_31_1","first-page":"2053","article-title":"High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, inmunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF8","volume":"58","author":"Tanaka A.","year":"1998","journal-title":"Cancer Research"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010753826788"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.2164\/jandrol.107.002683"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(97)00022-8"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1159\/000051236"}],"container-title":["International Journal of Andrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2605.2008.00906.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2605.2008.00906.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:25:13Z","timestamp":1738283113000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2605.2008.00906.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,4]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["10.1111\/j.1365-2605.2008.00906.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2605.2008.00906.x","archive":["Portico"],"relation":{},"ISSN":["0105-6263","1365-2605"],"issn-type":[{"type":"print","value":"0105-6263"},{"type":"electronic","value":"1365-2605"}],"subject":[],"published":{"date-parts":[[2009,11,4]]}}}